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stable expression of 53BP1 mCherry (RPE CCNB YFP -53BP1 mCherry ) (9) (Fig. 1A) . While the addition of aphidicolin had no effect on cells in G2-phase (identified by Cyclin B1 expression), cells that progressed through S-phase in the presence of aphidicolin showed a clear decrease in mitotic entry over time (Fig. 1B) . This decrease in mitotic entry was accompanied by a concomitant increase in cells that abruptly lost Cyclin B1 expression ( Fig. 1C ). Based on previous findings (10) we hypothesized that the loss of Cyclin B1 expression may correspond to levels of DNA damage. Indeed, cells that degrade Cyclin B1 after progressing through S-phase with mild replication stress, display increased 53BP1 foci compared to control cells or cells that recovered from replication stress and progressed to mitosis (Fig. 1D ). Importantly, abrogation of DNA damage signaling by ATR inhibition caused an increase in 53BP1 foci number in G1 daughter cells (Fig. S1A ).
We and others have previously shown that loss of Cyclin B1 and other cell cycle targets after DNA double-stranded breaks (DSBs) is mediated via APC/C CDH1 -dependent protein-degradation, causing the cells to enter a state of senescence (10) (11) (12) . To examine whether the aphidicolin-induced loss of Cyclin B1 is caused by APC/C CDH1 activation, we depleted CDH1. Indeed, CDH1 knock-down prevented Cyclin B1 degradation in cells that progressed through S-phase in the presence of aphidicolin ( Fig. 1E & S1B ). Experiments using RPE-1 cells stably expressing the Fluorescent Ubiquitination-based Cell Cycle Indicator (FUCCI) probes hCDT1 (aa30/120)-mKO2 (degraded by SCF SKP2 in S/G2/Mphases, thus indicating G1-phase) and hGeminin(aa1-110)-mAG (degraded by APC/C CDH1 in G1-phase, thus indicating S/G2/M-phases) confirmed that APC/C CDH1 activation indeed occured in G2. Aphidicolin treatment of RPE-FUCCI cells resulted in the accumulation of 4n mKO2 + cells over time, showing that these cells lost the APC/C CDH1 target Geminin and SCF SKP2 activity without going through mitosis (Fig. 1F ). We and others previously demonstrated that the balance between a reversible arrest and the APC/C CDH1 -dependent cell cycle exit caused by DNA double strand breaks in G2-phase is be tipped towards cell cycle exit by p53-dependent p21 expression (10, 11) . Interestingly, we observe that APC/C CDH1 activation in response to aphidicolin is delayed but not abrogated in p21 (∆p21) and p53 (∆p53) knockout RPE-FUCCI cells (Fig. 1G ).
In G2, activation of APC CDH1 is prevented by CDK1/2-dependent phosphorylation of CDH1 (13, 14) . To characterize CDK activity following replication stress, we used the previously described CDK2-activity sensor in RPE CCNB YFP cells (9, 15) . We find that CDK2 activity is stable in G2 cells following mild replication stress in S phase and drops in synchrony with Cyclin B1 (Fig. 1H ). The simultaneous loss of CDK2 activity and APC/C CDH1 target Cyclin B1 is surprising, since APC/C CDH1 activation in response to DNA double strand breaks is described to depend on the premature loss of CDK activity (10, 11, (16) (17) (18) (19) . Therefore we expected CDK2 activity to drop before Cyclin B1, yet our results implicate that APC/C CDH1 can be activated despite the present level of CDK2 activity.
In addition to CDK1/2 mediated inhibition, the APC/C CDH1 inhibitor EMI1 blocks APC/C CDH1 activity during S/G2 and loss of EMI1 is sufficient for premature activation of APC/C CDH1 in G2 (17, (20) (21) (22) (23) . We therefore combined our RPE CCNB YFP -53BP1 mCherry cells with doxycycline inducible EMI1-overexpression (9) , to define the importance of EMI1 loss for APC/C CDH1 activation following replication stress. Overexpression of EMI1 prevented Cyclin B1 degradation and rescued mitotic entry of cells exposed to replication stress ( Fig. 1I & S1C ). As replication stress results predominantly in ATR/CHK1activating lesions (24), this raises the question whether sustained ATR-signaling is required to maintain cells arrested and induce cell cycle exit. To address this, we treated G2 cells that progressed through S phase in the presence of aphidicolin with the specific ATR inhibitor VE-821. ATR inhibition prevented Cyclin B1 degradation and resulted in immediate mitotic entry of almost all G2 cells that progressed through S phase in presence of aphidicolin ( Fig. 1I & S1C) . In contrast, aphidicolin-treated cells that did recover from replication stress in the DMSO-treated condition showed a clear delay in mitotic entry (Fig. 1I ). The rescue by ATR inhibition was distinct from the rescue observed upon EMI1 overexpression, since EMI1 expressing G2 cells still arrested for several hours before progressing into mitosis. These results show that sustained ATR activity maintains the G2 arrest that ultimately results in APC/C CDH1 -dependent cell cycle exit. Together, these results imply there are additional players in the replication stress checkpoint that steer the decision between entering mitosis or exiting G2 through regulation of APC/C CDH1 activation. Surprisingly, this regulation is not mediated through p53/p21 or Cyclin B/CDK1 signaling.
DNA damage results in the activation of a transcriptional program that promotes DNA repair and stalls cell cycle progression (25). To determine whether a similar transcriptional program is induced by the canonical replication stress checkpoint, we determined the transcriptome of control and aphidicolin-treated cells. We identified 272 genes that were differentially expressed upon replication stress ( Fig. 2A , log2fold -0.5<x>0.5, p <0,05, 155 down-and 117 up-regulated genes). Transcription factor binding sites (TFBS) analysis revealed a significant enrichment of Forkhead Box O (FOXO) target genes that were upregulated in response to aphidicolin ( Fig. 2A-B Collectively, these observations imply that FOXOs promote premature APC/C CDH1activation in response to replication stress. In order to test whether FOXOs play an essential role in this process, we generated RPE-FUCCI cells with a doxycycline-inducible shRNA that efficiently knocks down FOXO1 and FOXO3 (RPE-FUCCI-shFOXOs) (30-32).
Aditionally, to separate any FOXO-dependent effect from p53-and p21-mediated effects, we also introduced the inducible shFOXOs into ∆p21 and ∆p53 RPE-FUCCI cells.
Replication stress induced the expression of p21 in a p53-dependent manner and p53 and p21 expression are reduced in the absence of FOXOs, both in unperturbed conditions and after replication stress ( Fig. 3A) . While FOXO-dependent p53 activation is not required for replication stress-induced cell cycle exit ( Fig. 1G ). However, FOXO depletion itself did prevent replication stress-induced premature APC/C CDH1 activation in G2, uncovering an additional role for FOXO in the cellular response to replication stress ( Our data show that FOXOs can drive APC/C CDH1 activation following replication stress.
Indeed, we observed that the FOXO3.A3-induced loss of Geminin expression in RPE-FUCCI cells (4n mKO+ cells) is reduced upon CDH1 knock-down ( Fig. S4A-C ). In addition, FOXO3.A3 expression results in a gradual decrease in EMI1 expression in asynchronously cultured cells, which is in line with previous studies showing that EMI1 downregulation is a prerequisite for cell cycle exit in G2 phase ( Fig. 4A & Fig. S4D ) (9, 11, 17) . To exclude that EMI1 downregulation is not simply the effect of a FOXO-induced G1 arrest, we sorted RPE-FUCCI-FOXO3.A3 cells based on mKO and mAG expression 8 and 16 hours after expression reduced mitotic entry of G2 cells due to premature APC/C CDH1 activation ( Fig.   4F ), simultaneous expression of EMI1 blocked APC/C CDH1 activation in G2, allowing cells to enter mitosis ( Fig. 4F ). Subsequently, cells arrested at metaphase as a consequence of high EMI1 levels in mitosis ( Fig. 4F& S4F) (33) .
We noticed that endogenous EMI1 levels still decreased in FOXO3.A3-and EMI1overexpressing cells ( Fig. 4E ), suggesting that transcriptional repression by FOXOs is responsible for reduced endogenous EMI1 expression. If FOXOs regulate EMI1 levels in S/G2 phase in response to replication stress, loss of FOXOs should stabilize EMI1 levels.
Indeed, aphidicolin-induced loss of EMI1 in S/G2-phase cells is prevented upon FOXO depletion ( Fig. 4G-H ). Hence, we conclude that FOXO-induced APC/C CDH1 -activation is mediated via repression of EMI1.
Although ~20% of all genes in the genome have FOXO binding elements in their promoters, FOXO binding sites are absent directly upstream of EMI1, implying that EMI1 transcription is not suppressed by FOXOs binding to its promoter directly (34, 35) . The main transcription factor driving EMI1 expression is E2F1 (21) , and previous studies have shown that FOXOs can bind to E2F1 and alter E2F1 target gene expression (32) .
Indeed, co-immunoprecipitation (co-IP) experiments using GFP-FOXO1/3 and HA-E2F1
confirmed that FOXOs can bind to E2F1 ( Fig. S5A ). To test whether FOXOs indeed affect E2F1-dependent transcription of EMI1 and other genes, we performed Chromatin-IP (ChIP) experiments. We found that binding of endogenous E2F1 to the promoter of EMI1 as well as two other canonical E2F1 targets (Cyclin E (CCNE2) and A (CCNA2)) was reduced when FOXO3.A3 was expressed ( Fig. 4I ). Accordingly, the expression of E2F1 target genes (E2F1 itself, CCNE2 and CCNA2) was reduced ( Next, we determined whether cells that activate APC/C CDH1 in G2-phase truly switch to a G0/G1 state after EMI1 downregulation. To this end, we sorted RPE-FUCCI- repression precedes APC/C CDH1 activation. Additionally, P27 and p21 are not induced, in line with the fact that SCF SKP2 mediates their degradation in S/G2 cells (36, 37) . Importantly, 4n mKO+ cells resemble G1 cells as expression of EMI1, Cyclin A, Cyclin B, SKP2 and phosphorylation of RB are absent. The high p27 and p21 levels in 4n mKO+ cells suggest that these cells are arrested. Finally, this experiment also confirms our initial observation that APC CDH1 activation is not preceded by CDK inhibition as p27 and p21 only increase after the APC/C is activated. Collectively these data show that FOXOdependent premature activation of the APC/C CDH1 prevents mitotic entry and in stead reverts the cells back into a 4N G1-like cellular state.
Conclusion & Discussion
Here we investigated the cellular response to replication stress, and find that cells monitor the presence of residual damage when progressing from S to G2 phase. We identified that a fraction of cells initiates cell cycle exit from G2 phase in response to replication stress. This is in contrast to earlier work that suggested that both transformed and non-transformed cells that experienced replication stress progress through mitosis, resulting in chromosomal aberrations and 53BP1-foci in G1-phase (3) (4) (5) . In agreement with previous reports, we show that G2 phase can be extended in an ATR-dependent manner, to provide time for DNA repair (5) . However, if repair is not successful within ~24 hours, APC/C CDH1 is activated and cells exit the cell cycle. It has previously been shown that DSBs in G2 phase may cause premature APC/C CDH1 -activation, resulting in irreversible withdrawal from the cell cycle (9) (10) (11) (12) 17) . Premature APC/C CDH1 -activation is preceded by p21-dependent nuclear entrapment of Cyclin B1-CDK complexes, which renders it inert for CDK (re-)activation (10, 18) . Intriguingly, here we find that CDK2 remains active during a replication stress-induced G2 arrest, and that APC/C CDH1 can be activated independent from p53, p21 or CDK2 inhibition. This leads to the interesting conclusion that APC/C CDH1 can be activated after replication stress in cells containing active CDK-complexes. We find that aphidicolin-induced APC/C CDH1 -activation is dependent on the repression of EMI1. FOXOs act as a timer to restrict the window during which cells may recover from replication stress, by gradually decreasing EMI1 levels through removing E2F1 from the EMI1 promoter ( Fig. 4M ). Alteration of E2F1 dependent transcriptional output by FOXOs has been reported previously for genes involved in apoptosis, and we now show that this mechanism of action is also applicable to cell cycle regulation in S/G2-phase (32) .
Interestingly, FOXOs and p53/p21 co-operate to restrict the time during which replication stress induces a reversible cell cycle arrest. On the one hand, FOXOs support the checkpoint and sensitize the APC/C CDH1 to activation, on the other hand p21 inhibits CDK activity. Combined, this results in a robust switch in which APC/C CDH1 -activation can revert the cell from a S/G2 state into G0/G1. Next to indirectly regulating the APC/C CDH1 , we observed that FOXOs are required for the establishment of the replication stress checkpoint. As FOXOs have been implicated to play a similar role in ATM/CHK2 mediated DSB repair, it will be interesting to investigate the FOXO-dependent mechanisms controlling the establishment of the replication stress checkpoint (38) (39) (40) .
Noteworthy, FOXOs have been suggested to play a role in inducing a G2 arrest, but these conclusions were based solely on DNA content analysis (41) (42) (43) (44) . As we do not observe mAG+ cells after FOXO activation, it's tempting to speculate that the previously reported FOXO-induced G2 arrest in fact represent cells that exited G2 and are in a G0/G1 state with 4n DNA.
Combined, our results establish a novel role for FOXOs in the replication stress response. FOXOs cooperate with the ATR/CHK1 and p53/p21 response both by supporting the establishment of a checkpoint and simultaneously restricting the time in which cells are allowed to resolve the damaged DNA. Importantly, deregulation of this FOXO driven timer gives cells the opportunity to divide with higher levels of replication stress, potentially promoting cellular transformation.
Materials & Methods

Cell culture
hTERT-immortalized Retinal Pigment Epithelial cells (RPE-1) were cultured in DMEM-F12 (Lonza) containing 10% FBS (Bodinco), 100U/ml penicillin and 100mg/ml streptomycin (Lonza). For doxycycline treatment 200 ng/ml Doxycycline (Sigma) was used for the duration of indicated times. RPE-1 cells in which a fluorescent tag was introduced in one allele of Cyclin B1 (RPE CCNB1 YFP ) have been described before (43) .
RPE-CCNB1 YFP -53BP1 mCherry , RPE CCNB1 YFP -EMI1 mTurq2 -53BP1 mCherry cells and RPE-CCNB1 YFP -DHB mCherry cells were described before (11) . Generation of RPE-FUCCI cells was previously described. Cells were treated with 0,2µM, 0,4µM aphidicolin (Sigma) for the indicated times. 0,2µM is used to induce replication stress from which cells can recover. 0,4µM induces a S/G2 arrest and was used to study APC CDH1 activation and replication stress checkpoint establishment.
Constructs, lentiviral transduction and transfections
Lentiviral cDNA expression vectors expressing FOXO3.A3 were generated using Gateway cloning in the pINDUCER20 (Addgene #44012) doxycycline inducible expression system (45) . The lentiviral construct pCW-mTurqouise-EMI1 was generated as previously described (19) . Transfecting third generation packaging vectors using Poly-ethylenimine into HEK293T cells generated lentiviral particles. Transfection of pTON-BIOPS-Flag-EGFP-FOXO1/FOXO3 and pCDNA-HA-E2F1 in HEK293T cells was performed using ExtremeGene 9 (Roche). Transfection of siRNA smartpools targeting EMI1, FZR1/CDH1
and E2F1 was performed using lipofectamine (Life Technologies).
CRISPR/Cas9 mediated knockouts we generated as previously described in (46) Briefly, pX330 was transfected in for both TP53 and CDKN1A knockout generation.
Subsequently, cells were treated with 5µM Nutlin-3a for 7 days to select out TP53 and CDKN1A deficient cells. and γH2AX foci was performed with a custom written ImageJ script that was described previously (19) ,
Immunoblotting & antibodies
RT-qPCR
mRNA was isolated from live cells using the Qiagen RNeasy kit (Qiagen) and cDNA synthesis was performed using the iScript cDNA synthesis kit (BioRad). Real-time PCR was performed using Fast Start Universal SYBR Green Master (ROX) mix (Roche) in the CFX Connect Real-time PCR detection system (BioRad). Target genes were amplified using specific primer pairs (Supplemental table 1) and specificity was confirmed by analysis of the melting curves. Target gene expression levels were normalized to GAPDH and HNRNPA1 levels.
Flow cytometry
For DNA content profiling and sorting, live cells were incubated with 10 µg/ml Hoechst33342 for 30 min. at 37°C. After incubation cells were trypsinized and transferred to normal culture medium before measuring. mKO-hCDT1, mAG-hGeminin and Hoechst33342 intensity was measured using a BD LSR Fortessa Flow cytometer or BD Aria II FACS (BD bioscience). 
Live cell imaging and tracking
